Precision Wealth Strategies, LLC

Position in EXEL — Exelixis, Inc.

CIK 1844197 SAINT LOUIS, MO

Position in EXEL

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$577,985

New position

Shares Held

13,476

first reported quarter

Ownership

0.005%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Precision Wealth Strategies, LLC holds $2,065,005 across 3 Biotechnology names. EXEL ranks #2 (28.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TBPH	Theravance Biopharma, Inc.	62,815	$1,019,487
2	EXEL	Exelixis, Inc. This page	13,476	$577,985
3	HALO	Halozyme Therapeutics, Inc.	7,234	$467,533

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$577,985	13,476	—	Shares	Sole	2026-05-06
No filing history on record for this holder in this stock.